We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$131B
AUM Growth
+$13.8B
Cap. Flow
+$6.04B
Cap. Flow %
4.61%
Top 10 Hldgs %
44.72%
Holding
4,042
New
364
Increased
2,601
Reduced
814
Closed
133

Sector Composition

Rank Sector Weight
1 Technology 8.26%
2 Financials 3.77%
3 Consumer Discretionary 2.12%
4 Communication Services 1.89%
5 Healthcare 1.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TR icon
2651
Tootsie Roll Industries
TR
$2.82B
$535K ﹤0.01%
+13,154
New +$498K
RGEN icon
2652
Repligen
RGEN
$7.44B
$535K ﹤0.01%
4,005
-435
-10% -$52.8K
GTM
2653
ZoomInfo Technologies
GTM
$861M
$535K ﹤0.01%
49,045
+9,605
+24% +$103K
SDOG icon
2654
ALPS Sector Dividend Dogs ETF
SDOG
$1.41B
$533K ﹤0.01%
8,852
+467
+6% +$27.6K
BAR icon
2655
GraniteShares Gold Shares
BAR
$1.37B
$533K ﹤0.01%
14,000
-576
-4% -$19.7K
OXY.WS icon
2656
Occidental Petroleum Corp Warrants
OXY.WS
$33.2B
$532K ﹤0.01%
20,866
+163
+0.8% +$3.81K
DEA
2657
Easterly Government Properties
DEA
$1.18B
$531K ﹤0.01%
+23,153
New +$526K
SHC icon
2658
Sotera Health
SHC
$4.95B
$530K ﹤0.01%
33,725
+13,539
+67% +$190K
BSAC icon
2659
Banco Santander Chile
BSAC
$15.8B
$530K ﹤0.01%
20,016
+3,162
+19% +$77.5K
ARKW icon
2660
ARK Web x.0 ETF
ARKW
$1.64B
$530K ﹤0.01%
3,038
+412
+16% +$65.4K
XENE icon
2661
Xenon Pharmaceuticals
XENE
$6.32B
$530K ﹤0.01%
+13,210
New +$465K
SFL icon
2662
SFL Corp
SFL
$1.59B
$530K ﹤0.01%
70,407
+260
+0.4% +$2.24K
MRC
2663
DELISTED
MRC Global
MRC
$529K ﹤0.01%
36,685
+7,066
+24% +$101K
METV icon
2664
Roundhill Ball Metaverse ETF
METV
$210M
$528K ﹤0.01%
25,613
JOET icon
2665
Virtus Terranova US Quality Momentum ETF
JOET
$240M
$528K ﹤0.01%
+12,266
New +$511K
NVDA icon
2666
PUT
NVIDIA
NVDA
$5.01T
$528K ﹤0.01%
433,800
-148,200
-25% -$25.8M
TRUP icon
2667
Trupanion
TRUP
$1.05B
$527K ﹤0.01%
12,183
-329
-3% -$15.6K
AGIO icon
2668
Agios Pharmaceuticals
AGIO
$2.16B
$527K ﹤0.01%
13,119
+280
+2% +$10.5K
FIVN icon
2669
FIVE9
FIVN
$1.77B
$526K ﹤0.01%
21,746
+14,092
+184% +$373K
LBTYA icon
2670
Liberty Global Class A
LBTYA
$3.31B
$526K ﹤0.01%
+45,920
New +$505K
HUT
2671
Hut 8
HUT
$12.4B
$526K ﹤0.01%
+15,117
New +$384K
TRC icon
2672
Tejon Ranch
TRC
$476M
$524K ﹤0.01%
32,794
+5,135
+19% +$89.5K
SHYM
2673
iShares Short Duration High Yield Muni Active ETF
SHYM
$789M
$523K ﹤0.01%
23,423
OXM icon
2674
Oxford Industries
OXM
$577M
$523K ﹤0.01%
12,901
-665
-5% -$28.8K
PTON icon
2675
Peloton Interactive
PTON
$2.63B
$522K ﹤0.01%
58,005
+16,680
+40% +$124K

Similar funds

Creative Planning's Q3 2025 Portfolio in Review

As of Q3 2025, Creative Planning held 4,042 positions worth $131B, up 12% from $117B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Creative Planning deployed $6.04B of net new capital in Q3 2025, opening 364 new positions and adding to 2,601 existing holdings. Its largest new stake was Amrize Ltd: 170,878 shares worth $8.29M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $232M trimmed.

  • Creative Planning's largest Q3 2025 buy was Amrize Ltd: 170,878 shares worth $8.29M.
  • Creative Planning added most to Vanguard Total Bond Market in Q3 2025, an estimated $740M increase.
  • Creative Planning's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $232M.
  • Creative Planning fully exited Ansys in Q3 2025, selling an estimated $4.86M.
  • Creative Planning's ten largest holdings make up 45% of its $131B portfolio in Q3 2025.
  • Creative Planning opened 364 new positions and closed 133 in Q3 2025.
  • Creative Planning's portfolio value rose 12% quarter-over-quarter to $131B.

Based on Creative Planning's 13F filing for Q3 2025, filed 14 Nov 2025.